Adam K. Simpson - 26 Jan 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Jan 2022
Net transactions value
+$90,968
Form type
4
Filing time
28 Jan 2022, 17:04:57 UTC
Previous filing
02 Aug 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $14,082 +16,764 +13% $0.8400* 141,764 26 Jan 2022 Direct
transaction ICVX Common Stock Options Exercise $76,886 +73,929 +52% $1.04* 215,693 26 Jan 2022 Direct
transaction ICVX Common Stock Gift $0 -125,000 -16% $0.000000 656,576 21 Dec 2021 By family trust
transaction ICVX Common Stock Gift $0 +125,000 +3100% $0.000000 129,032 21 Dec 2021 By family trust
transaction ICVX Common Stock Gift $0 -125,000 -19% $0.000000 531,576 21 Dec 2021 By family trust
transaction ICVX Common Stock Gift $0 +125,000 +3100% $0.000000 129,032 21 Dec 2021 By family trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -16,764 -22% $0.000000 59,870 26 Jan 2022 Common Stock 16,764 $0.8400 Direct F1
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -73,929 -14% $0.000000 438,605 26 Jan 2022 Common Stock 73,929 $1.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 2/21/2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F2 25% of the shares subject to the option vested on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.